EPIC Auditors offer an expert global GXP auditing and consultancy service to the pharmaceutical industry and to pharmaceutical manufacturing services in hospitals.
EPIC Auditors Management Team
Liz Allanson BSc (Pharm) MRPharmS, Company Director
Liz Allanson has been an independent pharmaceutical consultant for over 17 years and previously worked as a GMP Inspector in the MHRA Inspectorate for 18 years, culminating in the position of Manager of the MHRA GMP Inspection Unit. Throughout her time as a consultant, and as an MHRA Inspector, she performed countless GMP/GDP inspections/audits, of all major dosage forms, in the UK and worldwide. As a result, Liz has significant knowledge of current regulatory and GMP requirements in Europe, including the requirements for Investigational Medicinal Products and previously lectured on these subjects at QP training courses.
She is a pharmacist by profession and prior to joining the Inspectorate in 1986 was a Quality Assurance pharmacist in the UK National Health Service, responsible for managing the QA department connected to a large volume sterile manufacturing unit. Liz has particular expertise in quality management systems and now focuses on the strategic management of EPIC Auditors.
Honours degree in Pharmacy from John Moores University, Liverpool.
Liz is registered as a Lead Auditor with IRCA and is eligible as a Qualified Person under EC Directive 2001/83/EC.
Darren Jones BSc (Hons), CBiol, MRSB, Company Director & Senior Consultant
Darren Jones is an independent pharmaceutical consultant with experience in sterile, aseptic and non-sterile (liquid and solid) dosage form manufacturing operations for both commercial and clinical trial use. He worked for 4 years as a GMP Inspector for the MHRA being responsible for the inspection of manufacturing, testing and distribution sites in the UK and around the world. He has presented lectures to the PHSS and at the MHRA GMP symposium.
Prior to joining the MHRA Inspectorate, Darren spent 18 years at AstraZeneca in various QA, QP and management roles. He also spent some years working in API manufacture and has expertise in quality management systems and preparing sites for EU regulatory inspection.
Honours Degree in Applied Biology
Member of the Society of Biology
Eligible to act as a Qualified Person
IRCA Principal Auditor
Richard Andrews MSc, Managing Director & Senior Consultant
Richard Andrews is an accomplished quality professional with over 35 years experience working within Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) environments both in industry and for the UK medicines regulator (MHRA) where most recently as an Inspectorate Unit Manager he had overall responsibility for the GMP and GDP Inspectorates. Richard’s 18 years experience at the MHRA spanned the licensing and inspection of pharmaceutical manufacturers and distributors both in the UK and overseas, the development and implementation of regulations and European guidelines relating to pharmaceutical manufacture and distribution, the management of risk and noncompliance in these sectors and collaboration with other European and International regulatory authorities.
Prior to joining the MHRA Richard worked in the pharmaceutical industry for 17 years focusing mainly on the manufacture of bulk active pharmaceutical ingredients (API), gaining experience of process development and technical support and holding managerial positions in both Quality Assurance Production.
Masters Degree in Quality Management and Improvement
Studied BSc in Applied Chemistry
BTEC HNC in Chemistry
Michelle Yeomans MSc, Operations Manager & Senior Consultant
Michelle Yeomans is an accomplished quality professional with over 36 years’ experience working within Good Manufacturing (GMP), Good Clinical Practice (GCP) and Good Distribution Practice (GDP) environments both in industry and for the UK medicines regulator (MHRA).
During her 17 years at the MHRA Michelle contributed to the development of a national programme for GCP statutory inspections and the development of EMA GCP inspection procedures, the development of regulations and European guidelines relating to GMP for investigational medicine products (IMPs), and management oversight of the licensing and inspection of pharmaceutical manufacturers and distributors both in the UK and overseas as Inspectorate GMDP Operations Manager and Unit Manager.
Prior to joining the MHRA, Michelle spent 19 years working in the pharmaceutical industry, with experience of a variety of finished product dosage forms and clinical trial development. Her previous roles have included technical development and quality management roles, developing quality systems in manufacturing and laboratory environments for pharmaceutical and healthcare products. Michelle also has experience of leading quality management activities within a contract research environment including IMP manufacture and the conduct of clinical trials. She is recognised as a transitional Qualified Person for IMPs.
Masters Degree-Quality Management and Improvement
Post Graduate Diploma-Business Process Improvement and Quality Management
BTEC HNC-Pharmaceutical Science
Nicola Jones BSc (Hons), MRSC, Director of Finance
Nicola is an independent pharmaceutical consultant and EPIC Auditors Director of Finance. She has over 30 years pharmaceutical industry experience, is eligible to act as an EU Qualified Person and is a Quality Assurance expert for aseptic manufacture.
Nicola’s industry experience includes management roles within QA and QC, QP certification of clinical trial products, regulatory inspection preparation and leading both internal and external audits where her areas of expertise were Laboratory Compliance and Pharmaceutical Quality Systems.
Honours Degree in Chemistry
Member of the Royal Society of Chemistry
Eligible to act as a Qualified Person